Childhood Astrocytic Tumor — Trials

Childhood Astrocytic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

40 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT01553149	Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	completed	Phase 2	75	National Cancer Institute (NCI)NIH	4	Jan 7, 2025	clinicaltrials
NCT03879512	Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG	completed	Phase 1 / Phase 2	24	Wuerzburg University HospitalOTHER	1	Sep 19, 2024	clinicaltrials
NCT01236560

Data updated 5 days agoSource updated Sep 21, 2026source: clinicaltrials